CELZ News and Press, Creative Medical Technology Holdings Inc. From 10/07/25

PHOENIX, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today congratulated Mary E. Brunkow, Ph.D., Fre...

PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track design...

Hudson Global Inc. (HSON) is expected to report $0.17 for Q2 2025 Meritage Hospitality Group Inc. (MHGU) is expected to report $0.54 for Q2 2025 Genprex Inc. (GNPX) is expected to report for Q2 2025 Hour Loop Inc. (HOUR) is expected to report for Q2 2025 New Fortress Energy Inc. (...

Creative Medical Technology Holdings Inc. (CELZ) is expected to report $-0.63 for Q2 2025

PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a Notice ...

PHOENIX, July 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a Notice ...

2025-06-18 14:00:34 ET Biomea Fusion Falls 32% on Stock Offering Despite Promising Obesity Data Biomea Fusion Inc. ( BMEA ) dropped 31.72% to lead losses in the PRISM Emerging Global Healthcare Index after pricing a $40 million public offering of common stock and warrants at...

2025-05-12 15:59:35 ET Summary Initiating coverage on Creative Medical Technology Holdings with a Sell rating due to early-stage pipeline and significant downside risks outweighing potential upside. The company’s pipeline includes AlloStem for diabetes, AlloStemSpine for ba...

2025-05-08 18:48:19 ET Creative Medical Technology Holdings, Inc. (CELZ) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.85%. The average open to low on the day of earnings was -3.52%. ...

2025-05-08 18:43:19 ET Creative Medical Technology Holdings, Inc. (CELZ) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CELZ stock price following earnings has averaged ±1.43% , with ...